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Abstract— A convenient and efficient procedure for the synthesis of 4-arylchromenes, thiochromenes and related heterocycles via a four 
step sequence has been developed. The first three steps which involve hydration of alkynes, hydrazones formation and their Pd-coupling 
with ortho substituted aryl halides, furnished Z-trisubstituted olefins without any purification of the intermediates generated in each stage. 
These latter proved to be suitable precursors, in the last step, for the synthesis of the desired heterocycles of biological interest. © 2019 
Elsevier Science. All rights reserved 
——— 
* Corresponding author. Tel.: +33-1-46.83.58.87; fax: +33-1-46.83.58.28; e-mail: mouad.alami@u-psud.fr 
In an ongoing medicinal chemistry program directed 
toward the synthesis of anticancer1 substances and 
particularly antimitotic agents,2 we recently found that 
isocombretastatin A-4 (isoCA-4),3 the third and 
“forgotten” structural isomer of the natural product, 
displayed biological activities comparable to that of CA-4 
(Figure 1). This substance having a 1,1-diarylethylene 
scaffold4 is easy to synthesize without the need to control 
the olefin geometry. Bioisosteric replacement was 
successfully extended to compounds 1 and 2 having a tri- 
or tetra-substituted double bond.3a,5 In this article we 
reconfigured the substitution pattern around the double by 
the preparation of 4-arylchromenes of type 3, that could 
be considered as constraint analogues of isoCA-4, in 
which the double bond is tri-substituted (Scheme 1). 
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Figure 1. Structure of CA-4, isoCA-4 and synthetic 
tubulin assembly inhibitors 1 and 2. 
A survey of the literature showed that few routes have 
been developed for the preparation of 4-arylchromenes 3, 
including the coupling of 4-OTf-chromene derivatives 
with arylboronic acids,6 a reaction of 4-methoxycarbonyl-
chromane-3-one with aryllead triacetates,7 ring-closing 
metathesis8 and so on.9 
The strategy envisioned herein to prepare the target 
chromenes 3 involves a four step-sequence based on 
regioselective hydration of alkynes10 7 or 8, N-
tosylhydrazones 5 and 6 formation, followed by their Pd-
coupling reaction3a,11 with appropriate aryl halides (path a 
or b, Scheme 1) and subsequent O-cylization.  
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Scheme 1. Retrosynthetic analysis of targeted 4-
arylchromene derivatives 3. 
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Previously we reported the hydration of internal alkynes, 
in EtOH under a catalytic amount of p-toluenesulfonic 
acid (PTSA). Under this environmentally friendly 
procedure, aliphatic arylalkynes were regioselectively 
converted into their corresponding carbonyl compounds 
according to Markovnikov’s rules.12 Because the reactions 
conditions for the hydration of arylalkynes and the 
tosylhydrazones formation from the corresponding 
carbonyl compounds are similar (cat. PTSA in EtOH), we 
decided to investigate whether it might be possible to 
carry in a one-pot fashion the sequential hydration of 8, in 
situ N-tosylhydrazones 6 formation, and palladium-
catalyzed coupling reaction with ortho substituted aryl 
halides according to path a (Scheme 1). Herein we 
reported the results of this study and demonstrated that the 
resulting olefins 4 are suitable precursors of 4-
arylchromenes 3 and related heterocycles. 
At the outset of this work, the one-pot synthesis of 4a 
(Table 1, entry 1) was first examined from alkyne 8a, 
easily available by Sonogashira-Linstrumelle coupling 
reaction.13 We then decided to achieve this transformation 
in a sequential way by heating 8a in EtOH in the presence 
of PTSA (20 mol%) in a first step then, by introducing N-
tosylhydrazine in a second step, and finally by coupling 
the in situ obtained hydrazone with ortho substituted aryl 
iodide 9a using PdCl2(MeCN)2/Xphos as the catalytic 
system.14 Under these conditions, we were pleased to 
observe that this sequential process worked very well and 
provided the desired tri-substitued olefin 4a in a 68% 
overall yield (Entry 1, Table 1).15 One can note that 4a 
was isolated with a marked Z-selectivity of >9:1. To the 
best of our knowledge, only one example with such Z-
preference was reported very recently by Barluenga et 
al.16 in the synthesis of a 2-arylacrylate, readily obtained 
from the coupling of a functionalized hydrazone with an 
ortho substituted aryl bromide. On the basis of these 
observations, we reasoned that this co-operative ortho 
effect could be exploited to give Z-trisubstitued olefins 4 
with high diastereoisomeric ratio (dr).  
In seeking a further enhancement of Z-selectivity, we next 
applied the one-pot three-step sequence to ortho 
substituted aryl halides 9b-f (entries 2-6). In most cases 
studied, an improvement in dr (Z/E from >9:1 to 100:0) 
was observed in comparison to the aforementioned result 
obtained in entry 1. As expected, the process can be 
accomplished also with other aliphatic arylalkynes 
(Entries 7-10). Alkyne 8b with a butynol chain (Entries 7-
9), provided olefins 4g-i with good overall yields (55-
71%). Finally alkyne 8c having an n-pentyl chain was 
also efficiently transformed into olefin 4j as a single Z-
isomer in a 51% overall yield (entry 10). Altogether, these 
results (entries 7-10) clearly demonstrated that the 
substituent attached to the triple bond had no deleterious 
effect on the Z/E distribution, and olefins 4g-j were 
isolated with a total Z-preference. 
In the coupling step of N-tosylhydrazones with aryl 
halides, a migratory insertion of Pd carbene species has 
been suggested as the key step.3a According to this 
reaction mechanism, coupling of N-tosylhydrazone 6a 
with ortho iodoanisole (path a, Scheme 2) would form Pd 
carbene species I, whereas the reaction of ortho methoxy 
N-tosylhydrazone 5a with 4-iodoanisole would furnish II 
(path b, Scheme 2). These intermediates species I and II 
should evolve according to the migratory insertion of the 
anisyl ring to give the same alkylpalladium complex III. 
Further -hydride elimination on III would give olefin 
4d, logically with the same diastereoisomeric ratio. To 
check this hypothesis, we carry out the coupling of ortho 
methoxy N-tosylhydrazone 5a with 4-iodoanisole 
according to path b (Scheme 2). Although 4d was formed 
in a low 18% yield, a similar dr (Z/E = ca. 19:1) was 
observed and may be compare to the one obtained 
according to path a (Entry 4, Table 1). 
Pd
I
OEt
OMe
MeO
Pd
I
OEt
MeO
OMe
OEt
PdI
NNHTs
OEt
MeO
NNHTs
OEt
OMe
I
OMe
I
MeO
+ +
path a path b
MeO
OMe
migratory
insertion
migratory
insertion
-hydride
elimination
I II
III
4d
6a 5a
 
Scheme 2. Palladium-catalyzed formation of olefin 4d 
according paths a and b. 
Altogether, the results depicted in Table 1 show that the 
use of ortho substituted aryl halides as electrophilic 
partners in the coupling with N-tosylhydrazones provides 
mainly to exclusively olefins 4 with a Z-configuration, 
even if the exact origin of this diastereoselectivity remains 
unclear. 
To achieve our goal, we next treated olefins having an 
ortho OMOM substituent 4a, 4f and 4g in acidic media. 
Thus, when heating 4a and 4f with PTSA in EtOH we 
were delighted to observe rapidly the formation of the 
desired 4-arylchromene derivatives 3a,b in excellent 
yields (Scheme 3).17 With substrate 4g, TfOH was found 
to be superior than PTSA, and achieve the cyclization 
reaction efficiently providing the expected 5-aryl-2,3-
dihydrobenzo[b]oxepine 10. 
To extend the scope of this transformation, we finally 
examined the cyclization of olefin 4b having an ortho 
methylthio substituent. We were pleased to find that upon 
heating in the presence of TfOH, 4b cyclized to afford 
after hydrolysis the arylthiochromenylium hydroxide 11 
in good yield (85%). If the cyclization reaction of 4b was 
conducted in the presence of TfOH followed by addition 
of Et3N, the expected 1-arylthiochromene 12 was isolated 
in a 78% overall yield (Scheme 3). 
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Table 1. Stereoselective synthesis of trisubstituted olefins 4 from arylalkynes 8 through a one-pot three step sequence based 
on hydration of 8, N-tosylhydrazone formation and Pd-catalyzed coupling reaction with ortho substituted aryl halides.  
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Entry Alkyne 8 Aryl halide 9 Product Z-4  Yield (%)a Z:E Ratiob 
1 
 
8a 
 
9a  
 
4a 68 9:1 
2 8a 9b  
OEt
MeO
SMe
 
4b 93 100:0 
3 8a 9c  
 
4c 80 100:0 
4 8a 9d 
I
OMe  
OEt
MeO
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4d 77 >9:1c 
5 8a 9e 
I
Me
Me
 OEt
MeO
Me
Me
 
4e 68 19:1 
6 8a 9f  
 
4f 57 >19:1 
7 
 
8b 
9a  
 
4g 71 19:1 
8 8b 9f  
 
4h 58 100:0 
9 8b 9b  
 
4i 55 100:0 
10 
 
MeO
 
8c 
 
9c  
MeO
NO2
MeO
 
4j 51 100:0 
a Overall isolated yield based on alkyne 8. All reactions were performed according to general procedure; see: ref.15. 
b Ratio of stereoisomer E and Z determined in the crude reaction mixture by 1H NMR. The Z-configuration of all compounds described herein was assigned 
by NOESY experiments. 
c A low diastereoisomeric Z-preference (dr  = 1.5:1, yield = 78%) was obtained when using 3-iodoanisole instead of 2-iodoanisole. 
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Scheme 3. Reagents and conditions: (a) PTSA (3 equiv.) 
EtOH, reflux, 1 h, 3a: 98%, 3b: 78%. (b) TfOH cat. 
dioxane, reflux, 15 h, 62%. (c) TfOH cat. CH2Cl2, rt, 30 
min., 85% (d) (i) TfOH cat. CH2Cl2, 20 °C, 30 min; (ii) 
Et3N (2 equiv.) EtOH, 20 °C, 78%. 
In summary, we have described a convenient sequence to 
4-arylchromenes and related heterocycles. This protocol is 
based on the one-pot regioselective hydration of alkynes, 
N-tosylhydrazones formation, followed by their 
palladium-catalyzed coupling with aryl halides to form 
trisubstituted olefins with Z-selectivity. Further Brönsted 
acid-mediated cylization provided the desired 
heterocycles. This process is very convenient and efficient 
because it significantly reduced reaction times and tedious 
procedures such as work-up and purification at each step. 
Reaction is general with respect to alkyne and ortho 
substituted aryl halides. Good yields, convenient isolation 
of the targeted heterocycles are the distinct characteristics 
of the developed protocol. Studies are currently under 
way for the synthesis of heterocycles related to isoCA-4 
and will reported in due course. 
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